Skip to main content

TREACE MEDICAL CONCEPTS, INC. (TMCI) Stock Forecast 2025 - AI Price Prediction & Analysis


TREACE MEDICAL CONCEPTS, INC. (TMCI) AI Stock Price Forecast & Investment Analysis

TREACE MEDICAL CONCEPTS, INC. Stock Price Chart and Technical Analysis

Loading TREACE MEDICAL CONCEPTS, INC. interactive price chart and technical analysis...

TREACE MEDICAL CONCEPTS, INC. (TMCI) - Comprehensive Stock Analysis & Investment Research

Deep dive into TREACE MEDICAL CONCEPTS, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about TREACE MEDICAL CONCEPTS, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For TREACE MEDICAL CONCEPTS, INC.: TREACE MEDICAL CONCEPTS, INC. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

TREACE MEDICAL CONCEPTS, INC. (Stock Symbol: TMCI) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 371 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing TREACE MEDICAL CONCEPTS, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TREACE MEDICAL CONCEPTS, INC.: With $202M in annual revenue and -30.3% net margin, the company demonstrates developing profitability.

Annual Revenue: $202 million generating a -30.3% net profit margin .

Market Capitalization: $430 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -69.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for TREACE MEDICAL CONCEPTS, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For TREACE MEDICAL CONCEPTS, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TREACE MEDICAL CONCEPTS, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: TREACE MEDICAL CONCEPTS, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For TREACE MEDICAL CONCEPTS, INC.: Market positioning analysis based on available financial and operational metrics.

TREACE MEDICAL CONCEPTS, INC. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 80.6% gross margin, indicating strong pricing power and operational efficiency.

TREACE MEDICAL CONCEPTS, INC. (TMCI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TREACE MEDICAL CONCEPTS, INC. stock analysis.

Loading TREACE MEDICAL CONCEPTS, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into TREACE MEDICAL CONCEPTS, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if TREACE MEDICAL CONCEPTS, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For TREACE MEDICAL CONCEPTS, INC.: With a P/E ratio of -7.47, the market sees the stock as potentially undervalued.

P/E Ratio -7.47x
P/B Ratio 4.40x
Market Cap $430M
EPS $-0.99
Book Value/Share $1.55
Revenue/Share $3.19
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently TREACE MEDICAL CONCEPTS, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TREACE MEDICAL CONCEPTS, INC.: An ROE of -69.6% indicates room for improvement in shareholder value creation.

ROE -69.6%
ROA -29.6%
ROIC -30.5%
Gross Margin 80.6%
Operating Margin -30.7%
Net Margin -30.3%
EBT Margin -25.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess TREACE MEDICAL CONCEPTS, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For TREACE MEDICAL CONCEPTS, INC.: A current ratio of 8.28 indicates strong liquidity.

Current Ratio 8.28x
Quick Ratio 7.44x
D/E Ratio 0.51x
Financial Leverage 1.69x
Interest Coverage -5.8x
Working Capital $29M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal TREACE MEDICAL CONCEPTS, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For TREACE MEDICAL CONCEPTS, INC.: Free cash flow of $-28M indicates cash challenges that need attention.

Operating Cash Flow $-24M
Free Cash Flow $-28M
Capital Spending $-4M
FCF/Sales -26.7%
CapEx/Sales 3.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively TREACE MEDICAL CONCEPTS, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For TREACE MEDICAL CONCEPTS, INC.: An asset turnover of 1.14x demonstrates efficient asset utilization.

Asset Turnover 1.14x
Receivables Turnover 7.8x
Inventory Turnover 2.2x
Fixed Assets Turnover 10.5x
Days Sales Outstanding 47 days
Days Inventory 169 days
Payables Period 43 days
Cash Conversion Cycle 172 days
Understanding Financial Statement Data

What these metrics mean: Key figures from TREACE MEDICAL CONCEPTS, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For TREACE MEDICAL CONCEPTS, INC.: With annual revenue of $202M, TREACE MEDICAL CONCEPTS, INC. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $202M
Operating Income $-16M
R&D Expense $10M
SG&A Expense $92M
Cost of Goods Sold $18M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 87%
Cash & Short-term Investments 67%
Total Liabilities 41%
Short-term Debt 4%
Accounts Receivable 11%
Inventory 8%
Dividend & Shareholder Information
Shares Outstanding 63M
Growth Metrics (YoY)
EPS Growth -9.8%

Latest TREACE MEDICAL CONCEPTS, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting TREACE MEDICAL CONCEPTS, INC. (TMCI) stock price and investment outlook.

TREACE MEDICAL CONCEPTS, INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of TREACE MEDICAL CONCEPTS, INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $21M x 2.4x
ALUR Unlock Forecast - 30 Days FREE Trial $15M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $510M -1.4x 2.9x
ANIK Unlock Forecast - 30 Days FREE Trial $144M -4.3x 1.0x
AORT Unlock Forecast - 30 Days FREE Trial $1991M -198.2x 4.7x
APYX Unlock Forecast - 30 Days FREE Trial $116M -3.5x 16.1x
ARAY Unlock Forecast - 30 Days FREE Trial $177M -9.9x 2.2x
ATEC Unlock Forecast - 30 Days FREE Trial $2468M -7.4x 103.8x
ATRC Unlock Forecast - 30 Days FREE Trial $1812M -39.6x 3.9x
AVHHL Unlock Forecast - 30 Days FREE Trial $30M x x
BAX Unlock Forecast - 30 Days FREE Trial $11750M -94.9x 1.6x
BBNX Unlock Forecast - 30 Days FREE Trial $1069M x 3.5x
BDX Unlock Forecast - 30 Days FREE Trial $53180M 34.1x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $58M -5.7x 13.9x
BJDX Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.7x
BSX Unlock Forecast - 30 Days FREE Trial $150779M 61.0x 6.7x
BVS Unlock Forecast - 30 Days FREE Trial $477M -18.3x 3.0x
CARL Unlock Forecast - 30 Days FREE Trial $60M x x
CERS Unlock Forecast - 30 Days FREE Trial $284M -13.8x 5.1x
CLPT Unlock Forecast - 30 Days FREE Trial $718M -23.5x 36.4x
CODX Unlock Forecast - 30 Days FREE Trial $12M -0.7x 0.3x
CVRX Unlock Forecast - 30 Days FREE Trial $280M -5.5x 4.8x
DCTH Unlock Forecast - 30 Days FREE Trial $355M 160.2x 3.4x
DRTS Unlock Forecast - 30 Days FREE Trial $362M x 4.2x
DXCM Unlock Forecast - 30 Days FREE Trial $27152M 49.1x 10.6x
EBRCZ Unlock Forecast - 30 Days FREE Trial $427M x 8.6x
EMBC Unlock Forecast - 30 Days FREE Trial $822M 15.8x -0.8x
FEMY Unlock Forecast - 30 Days FREE Trial $23M -1.4x 15.2x
FOFA Unlock Forecast - 30 Days FREE Trial $7M x 12.7x
GIPL Unlock Forecast - 30 Days FREE Trial $7M x 36.1x
GKOS Unlock Forecast - 30 Days FREE Trial $4453M -46.3x 5.8x
GMED Unlock Forecast - 30 Days FREE Trial $8668M 24.1x 2.0x
GUTS Unlock Forecast - 30 Days FREE Trial $69M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $2466M 26.1x 2.8x
HRGN Unlock Forecast - 30 Days FREE Trial $29M x 38.2x
IART Unlock Forecast - 30 Days FREE Trial $1198M 200.2x 1.2x
ICCM Unlock Forecast - 30 Days FREE Trial $48M x 16.6x
ICUI Unlock Forecast - 30 Days FREE Trial $3034M -49.8x 1.4x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $27M x 6.2x
IINNW Unlock Forecast - 30 Days FREE Trial $10M x 2.4x
INBS Unlock Forecast - 30 Days FREE Trial $8M -0.3x 2.7x
INFU Unlock Forecast - 30 Days FREE Trial $207M 40.8x 3.8x
INSP Unlock Forecast - 30 Days FREE Trial $2312M 43.2x 3.4x
IRMD Unlock Forecast - 30 Days FREE Trial $987M 48.3x 10.5x
IRTC Unlock Forecast - 30 Days FREE Trial $5865M -20.2x 56.6x
KIDS Unlock Forecast - 30 Days FREE Trial $390M -20.7x 1.1x
KMTS Unlock Forecast - 30 Days FREE Trial $1438M x x
KRMD Unlock Forecast - 30 Days FREE Trial $196M -19.8x 11.9x
LMAT Unlock Forecast - 30 Days FREE Trial $2063M 43.4x 5.7x
LNSR Unlock Forecast - 30 Days FREE Trial $143M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $130M -0.6x 16.6x
LUNG Unlock Forecast - 30 Days FREE Trial $62M -4.3x 0.9x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $997M 30.5x 4.6x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $88624M 26.8x 19.2x
MMSI Unlock Forecast - 30 Days FREE Trial $4903M 41.1x 3.3x
NEPH Unlock Forecast - 30 Days FREE Trial $52M 39.1x 6.2x
NMTC Unlock Forecast - 30 Days FREE Trial $41M -1.7x 5.0x
NPCE Unlock Forecast - 30 Days FREE Trial $351M -10.4x 18.1x
NSPR Unlock Forecast - 30 Days FREE Trial $74M -4.3x 3.6x
NVCR Unlock Forecast - 30 Days FREE Trial $1519M -20.8x 4.4x
NXGL Unlock Forecast - 30 Days FREE Trial $20M -6.8x 4.3x
OBIO Unlock Forecast - 30 Days FREE Trial $153M -3.4x 1.5x
OFIX Unlock Forecast - 30 Days FREE Trial $636M -5.8x 1.4x
OSRH Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
OSUR Unlock Forecast - 30 Days FREE Trial $223M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $10M 0.1x 0.3x
PDEX Unlock Forecast - 30 Days FREE Trial $93M 10.3x 2.5x
PEN Unlock Forecast - 30 Days FREE Trial $9235M 67.4x 7.1x
PLRZ Unlock Forecast - 30 Days FREE Trial $6M x 0.3x
PLSE Unlock Forecast - 30 Days FREE Trial $1183M -2.6x 11.3x
PMI Unlock Forecast - 30 Days FREE Trial $37M x x
PODD Unlock Forecast - 30 Days FREE Trial $22912M 97.8x 15.7x
PRCT Unlock Forecast - 30 Days FREE Trial $2020M -45.4x 5.2x
PROF Unlock Forecast - 30 Days FREE Trial $165M x 4.2x
PSTV Unlock Forecast - 30 Days FREE Trial $57M -0.3x 18.8x
PYPD Unlock Forecast - 30 Days FREE Trial $51M x 2.5x
RCEL Unlock Forecast - 30 Days FREE Trial $106M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $35M x 13.0x
RMD Unlock Forecast - 30 Days FREE Trial $37558M 27.7x 6.3x
RSMDF Unlock Forecast - 30 Days FREE Trial $3625M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $27M -0.9x 0.4x
SGHT Unlock Forecast - 30 Days FREE Trial $275M -3.7x 3.9x
SIBN Unlock Forecast - 30 Days FREE Trial $676M -14.3x 4.0x
SKIN Unlock Forecast - 30 Days FREE Trial $185M -1.8x 2.5x
SNOA Unlock Forecast - 30 Days FREE Trial $6M -5.6x 1.6x
SNWV Unlock Forecast - 30 Days FREE Trial $266M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12297M 32.9x 3.4x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $8M -8.0x 25.6x
STIM Unlock Forecast - 30 Days FREE Trial $206M -1.0x 7.6x
STME Unlock Forecast - 30 Days FREE Trial $20M x x
STSS Unlock Forecast - 30 Days FREE Trial $5M -2.5x 0.3x
SYK Unlock Forecast - 30 Days FREE Trial $145259M 50.7x 12.4x
TCMD Unlock Forecast - 30 Days FREE Trial $342M 22.3x 1.8x
TELA Unlock Forecast - 30 Days FREE Trial $61M -1.8x 6.6x
TFX Unlock Forecast - 30 Days FREE Trial $5892M 31.0x 1.4x
TLSI Unlock Forecast - 30 Days FREE Trial $187M -3.6x -5.6x
TMCI Unlock Forecast - 30 Days FREE Trial $430M -7.5x 4.4x
TNDM Unlock Forecast - 30 Days FREE Trial $1031M -17.1x 7.7x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.4x
UFPT Unlock Forecast - 30 Days FREE Trial $1557M 44.7x 4.0x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $194M 15.5x 1.7x
VERO Unlock Forecast - 30 Days FREE Trial $4M 0.0x 1.8x
WST Unlock Forecast - 30 Days FREE Trial $20383M 44.4x 6.7x
XTNT Unlock Forecast - 30 Days FREE Trial $99M -478.8x 2.0x

Frequently Asked Questions - TREACE MEDICAL CONCEPTS, INC. Stock Forecast

How accurate are TREACE MEDICAL CONCEPTS, INC. stock predictions?

Our AI model shows a 36% Spearman correlation coefficient for TMCI predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence TREACE MEDICAL CONCEPTS, INC. stock price forecasts?

Our analysis considers TREACE MEDICAL CONCEPTS, INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is TREACE MEDICAL CONCEPTS, INC. a good investment in 2025?

Based on our AI analysis, TREACE MEDICAL CONCEPTS, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are TREACE MEDICAL CONCEPTS, INC. forecasts updated?

TREACE MEDICAL CONCEPTS, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced TREACE MEDICAL CONCEPTS, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TREACE MEDICAL CONCEPTS, INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...